Skip to main content

Mild Traumatic Brain Injury

0
Pipeline Programs
9
Companies
7
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
2 programs
Objective Dual-task Turning Measures for Return-to-duty AssessmentsN/A
Timing of RehabilitationN/A1 trial
Active Trials
NCT03479541Completed203Est. Sep 2023
TecTraum
TecTraumOH - Cleveland
2 programs
Pro-2-Cool DeviceN/A1 trial
TecTraum deviceN/A1 trial
Active Trials
NCT06929923Suspended72Est. Feb 2026
NCT03511339Completed174Est. May 2022
Sound Pharmaceuticals
1 program
Brief Cognitive RehabilitationN/A1 trial
Active Trials
NCT05315453Completed28Est. Oct 2022
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Multimodal AssessmentN/A1 trial
Active Trials
NCT04874389Unknown50Est. Aug 2021
Utah Medical
Utah MedicalIreland - Dublin
1 program
Objective Dual-task Turning Measures for Return-to-duty AssessmentsN/A
Courage Therapeutics
1 program
Objective Dual-task Turning Measures for Return-to-duty AssessmentsN/A1 trial
Active Trials
NCT03892291Completed185Est. Sep 2024
Life Molecular Imaging
Life Molecular ImagingGermany - Berlin
1 program
[18F]PI-2620PHASE_11 trial
Active Trials
NCT05337774Terminated18Est. Apr 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Life Molecular Imaging[18F]PI-2620
TecTraumPro-2-Cool Device
Sound PharmaceuticalsBrief Cognitive Rehabilitation
Angeles TherapeuticsMultimodal Assessment
Courage TherapeuticsObjective Dual-task Turning Measures for Return-to-duty Assessments
Oregon TherapeuticsTiming of Rehabilitation
TecTraumTecTraum device

Clinical Trials (7)

Total enrollment: 730 patients across 7 trials

NCT05337774Life Molecular Imaging[18F]PI-2620

Imaging [18F]PI-2620 and [18F]Florbetaben in Military Service Members With Blast Related Mild Traumatic Brain Injury

Start: Jun 2021Est. completion: Apr 202218 patients
Phase 1Terminated
NCT06929923TecTraumPro-2-Cool Device

Pro-2-Cool Pivotal Trial II

Start: Feb 2025Est. completion: Feb 202672 patients
N/ASuspended
NCT05315453Sound PharmaceuticalsBrief Cognitive Rehabilitation

Brief Telehealth Cognitive Rehabilitation Following Mild TBI

Start: Dec 2021Est. completion: Oct 202228 patients
N/ACompleted
NCT04874389Angeles TherapeuticsMultimodal Assessment

Multidimensional Classification of Mild Traumatic Brain Injury (mTBI)

Start: May 2021Est. completion: Aug 202150 patients
N/AUnknown
NCT03892291Courage TherapeuticsObjective Dual-task Turning Measures for Return-to-duty Assessments

Objective Dual-task Turning Measures for Return-to-duty Assessments

Start: Sep 2018Est. completion: Sep 2024185 patients
N/ACompleted
NCT03479541Oregon TherapeuticsTiming of Rehabilitation

Can Early Initiation of Rehabilitation With Wearable Sensor Technology Improve Outcomes in mTBI?

Start: Jul 2018Est. completion: Sep 2023203 patients
N/ACompleted
NCT03511339TecTraumTecTraum device

Pro-2-Cool Device Clinical Study

Start: Nov 2017Est. completion: May 2022174 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

9 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.